Nathan Qin spent fifteen years inside MedTech. R&D at Johnson & Johnson, Boston Scientific, and Siemens Healthineers. He founded qinnovativ medtech in 2012. He invested and built CASIS (France), a leader in cardiac MRI post-processing. He advises Keya Medical (China), Heartio (USA), Ligence (EU), and Cardio Flow Design (Japan). He founded CardiaX Intelligence in Seattle, USA, advancing AI-powered imaging diagnostics from concept to global market.

Sixty-five startups across the US, EU, and Asia. FDA submissions. NMPA registrations. Cardiac AI commercialisation. Fundraising. Cross-border market entry on three continents.

In 2025, Nathan launched NathanTwin — an AI digital twin encoding fifteen years of MedTech pattern recognition, available 24/7 for regulatory strategy, reimbursement planning, fundraising, and market entry questions. The Circle of Twins is a founding cohort of senior practitioners, each building an AI twin of their own expertise, with the mission to preserve Human Expert Judgement.

MFA, Umeå Institute of Design. Kellogg/WHU Executive MBA. PhD candidate in health economics (Sweden). Multiple patents. Senior Healthcare Shapers member.